Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 11, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 49
- +3 vs. Q1 2021
- Portfolio value
- $319.8M
- −$37.1M (−10.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RAPTRAPT Therapeutics, Inc. | COM | 570,000 | $18.1M | 5.7% | +570,000 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 135,000 | $17.8M | 5.6% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 185,000 | $16.1M | 5.0% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 850,000 | $15.8M | 4.9% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 205,000 | $15.8M | 4.9% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 875,000 | $15.0M | 4.7% | −300,000−25.5% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 700,000 | $14.6M | 4.6% | +100,000+16.7% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 1,600,000 | $13.0M | 4.1% | 00.0% | Unchanged | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,250,000 | $12.1M | 3.8% | −700,000−35.9% | Reduced | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 450,000 | $11.7M | 3.7% | −50,000−10.0% | Reduced | History |
| BIIBBiogen Inc. | COM | 32,500 | $11.3M | 3.5% | +12,500+62.5% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 285,000 | $9.53M | 3.0% | +35,000+14.0% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 50,000 | $8.08M | 2.5% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 275,000 | $7.17M | 2.2% | +275,000 | New | History |
| TGTXTG Therapeutics, Inc. | COM | 180,000 | $6.98M | 2.2% | −20,000−10.0% | Reduced | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 600,000 | $6.80M | 2.1% | −50,000−7.7% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 1,000,000 | $6.54M | 2.0% | +60,957+6.5% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 350,000 | $6.40M | 2.0% | +50,000+16.7% | Added | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $6.38M | 2.0% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $6.30M | 2.0% | −2,143,702−51.7% | Reduced | History |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $6.11M | 1.9% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 200,000 | $6.07M | 1.9% | +50,000+33.3% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 207,500 | $5.93M | 1.9% | +32,500+18.6% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 125,000 | $5.54M | 1.7% | −200,000−61.5% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $5.17M | 1.6% | 00.0% | Unchanged | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 75,000 | $5.17M | 1.6% | +75,000 | New | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $4.93M | 1.5% | +170,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 243,309 | $4.59M | 1.4% | +243,309 | New | History |
| ISEEIVERIC bio, Inc. | COM | 725,000 | $4.58M | 1.4% | −400,000−35.6% | Reduced | History |
| ACRSAclaris Therapeutics, Inc. | COM | 250,000 | $4.39M | 1.4% | −350,000−58.3% | Reduced | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.33M | 1.4% | 00.0% | Unchanged | History |
| CTICCti Biopharma Corp | COM | 1,600,000 | $4.00M | 1.3% | +850,000+113.3% | Added | History |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $3.89M | 1.2% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 125,000 | $3.53M | 1.1% | +125,000 | New | History |
| PCVXVaxcyte, Inc. | COM | 145,000 | $3.26M | 1.0% | +145,000 | New | History |
| IMUXImmunic, Inc. | COM | 265,000 | $3.25M | 1.0% | 00.0% | Unchanged | History |
| KDMNKadmon Holdings, Inc. | COM | 800,000 | $3.10M | 1.0% | +200,000+33.3% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $2.56M | 0.8% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 247,124 | $1.99M | 0.6% | −177,876−41.9% | Reduced | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 75,000 | $1.92M | 0.6% | +75,000 | New | History |
| CMRXChimerix Inc | COM | 200,000 | $1.60M | 0.5% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 75,000 | $1.58M | 0.5% | +75,000 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 100,000 | $1.36M | 0.4% | +100,000 | New | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $1.01M | 0.3% | 00.0% | Unchanged | History |
| OTICOtonomy, Inc. | COM | 450,000 | $1.00M | 0.3% | 00.0% | Unchanged | History |
| LRMRLarimar Therapeutics, Inc. | COM | 100,000 | $982.0K | 0.3% | +100,000 | New | History |
| MRNAModerna, Inc. | Stock | 4,000 | $940.0K | 0.3% | +4,000 | New | History |
| PRVBProvention Bio, Inc. | COM | 100,000 | $843.0K | 0.3% | +100,000 | New | History |
| TBIOTelesis Bio Inc. | COM | 35,000 | $770.0K | 0.2% | +35,000 | New | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2021 (11)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 225,000 | $9.65M | 2.7% | History |
| iShares Russell 2000 ETF464287655 | ETF | 30,000 | $6.63M | 1.9% | – |
| CNSTConstellation Pharmaceuticals Inc | COM | 275,000 | $6.43M | 1.8% | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 500,000 | $5.08M | 1.4% | History |
| NUVBNuvation Bio Inc. | COM CL A | 500,000 | $4.96M | 1.4% | History |
| KYNBKyntra Bio, Inc. | COM | 125,000 | $4.34M | 1.2% | History |
| IMVTImmunovant, Inc. | COM | 250,000 | $4.01M | 1.1% | History |
| NVAXNovavax Inc | COM NEW | 17,500 | $3.17M | 0.9% | History |
| SAGESage Therapeutics, Inc. | COM | 30,000 | $2.25M | 0.6% | History |
| DTILPrecision Biosciences Inc | COM | 200,000 | $2.07M | 0.6% | History |
| APVOAptevo Therapeutics Inc. | COM NEW | 50,000 | $1.53M | 0.4% | History |